Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever

International Journal of Clinical Practice

Volumn 62, Issue 5, 2008, Pages 754-761

  Ozel, A M ^a,b   Demirturk, L ^a   Aydogdu, A ^a   Gultepe, M ^a   Yazgan, Y ^a   Imirzalioglu, N ^a   Gurbuz, A K ^a   Narin, Y ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b Gastroenteroloji Klinigi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; C REACTIVE PROTEIN; CLARITHROMYCIN; CYTOKINE; FIBRINOGEN; INTERLEUKIN 6; LANSOPRAZOLE;

ADULT; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERADICATION THERAPY; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOMOZYGOSITY; HUMAN; MEFV GENE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; FAMILIAL MEDITERRANEAN FEVER; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-6; MALE;

EID: 42149129533     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01098.x     Document Type: Article

References (30)

1. Ben-Chetrit E, Levy M. Familial Mediterranean Fever. Lancet 1998 351 : 659 64.
2. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean Fever. A survey of 470 cases and review of the literature. Am J Med 1967 43 : 227 53.
3. Ozel AM, Demirturk L, Yazgan Y et al. Familial Mediterranean Fever. A review of the disease and clinical and laboratory findings in 105 patients. Dig Liver Dis 2000 32 : 504 9.
4. Pras E, Aksentijevich I, Gruberg L et al. Mapping of a gene causing Familial Mediterranean Fever to the short arm of chromosome 16. N Engl J Med 1992 326 : 1509 13.
5. Centola M, Wood G, Frucht DM et al. The gene for Familial Mediterranean Fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000 95 : 3223 31.
6. Kiraz S, Ertenli I, Arici M et al. Effects of colchicine on inflammatory cytokines and selectins in Familial Mediterranean Fever. Clin Exp Rheumatol 1998 16 : 721 4.
7. Ozyilkan E, Simsek H, Telatar H. Tumor necrosis factor in Familial Mediterranean Fever. Am J Med 1992 92 : 579 80.
8. Rozenbaum M, Katz R, Rozner I, Pollack S. Decreased interleukin 1 activity released from circulating monocytes of patients with Familial Mediterranean Fever during in vitro stimulation by lipopolysaccharide. J Rheumatol 1992 19 : 416 8.
9. Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H. Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in Familial Mediterranean Fever. J Rheumatol 1999 26 : 1983 6.
10. Gang N, Drenth JP, Langevitz P et al. Activation of the cytokine network in Familial Mediterranean Fever. J Rheumatol 1999 26 : 890 7.
11. Notarnicola C, Didelot MN, Seguret F, Demaille J, Touitou I. Enhanced cytokine mRNA levels in attack-free patients with Familial Mediterranean Fever. Genes Immun 2002 3 : 43 5.
12. Davydov L, Cheng JW. The association of infection and coronary artery disease: an update. Expert Opin Investig Drugs 2000 9 : 2505 17.
13. Diaz C, O'Callaghan CJ, Khan A, Ilchyshyn A. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study. Acta Derm Venereol 2003 83 : 282 6.
14. Moriyama T, Matsumoto T, Fuchigami T et al. Changes in Helicobacter pylori status in patients with rheumatoid arthritis under non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 2004 39 : 111 8.
15. Oldenburg B, Koningsberger JC, Van Berge Henegouwen GP, Van Asbeck BS, Marx JJ. Iron and inflammatory bowel disease. Aliment Pharmacol Ther 2001 15 : 429 38.
16. Hatz RA, Meimarakis G, Bayerdorffer E, Stolte M, Kirchner T, Enders G. Characterization of lymphocytic infiltrates in Helicobacter pylori-associated gastritis. Scand J Gastroenterol 1996 31 : 222 8.
17. Demirturk L, Ozel M, Cekem K, Yazgan Y, Gultepe M. Co-existence of Helicobacter pylori infection in patients with Familial Mediterranean Fever (FMF) and the effect of Helicobacter pylori on the frequency and severity of FMF attacks. Dig Liver Dis 2005 37 : 153 8.
18. Livneh A, Langevita P, Zemer D et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997 40 : 1879 85.
19. Konturek SJ, Konturek PC, Pieniazek P, Bielanski W. Role of Helicobacter pylori infection in extragastroduodenal disorders: introductory remarks. J Physiol Pharmacol 1999 50 : 683 94.
20. Bagci S, Toy B, Tuzun A et al. Continuity of cytokine activation in patients with Familial Mediterranean Fever. Clin Rheumatol 2004 23 : 333 7.
21. Oktem S, Yavuzsen SU, Sengul B et al. Levels of IL-6 and its soluble receptor (sIL-6R) in Familial Mediterranean Fever patients and their first degree relatives. Clin Exp Rheumatol 2004 22 : S34 6.
22. Kartunnen JJ, Niemela S, Karola T. Blood leucocyte differential in Helicobacter Pylori infection. Dig Dis Sci 1996 41 : 1332 6.
23. Gang N, Drenth J, Livneh A. Activation of the cytokine network in Familial Mediterranean Fever. In : Sohar E, Gafni J, Pras M, eds. Familial Mediterranean Fever I. International Conference (Book). London : Freund Publishing House Ltd, 1997 : 193 6.
24. Mayer P, Geissler K, Valent P et al. Recombinant human leukemia inhibitory factor is an inductor of acute phase proteins and raises the blood platelets in non human primates (Abstract). Clin Exp Rheumatol 1991 9 : 447.
25. Touitou I. (2000) The Spectrum of FMF Mutations. Familial Mediterranean Fever. 2nd International Congress, Antalya, Turkey (Abstract), pp. 23 6.
26. Yalçinkaya F, Çakar N, Misirlioglu M et al. Genotype-phenotype correlation in a large group of Turkish patients with Familial Mediterranean Fever: evidence for mutation-independent amyloidosis. Rheumatology 2000 39 : 67 72.
27. Dilsen N, Konice M, Aral O, Ocal L. (1990) General Characteristics of our 426 Cases of FMF. The First International Symposium of Recurrent Hereditary Polyserositis, 28-29 April, Amman Jordan (Abstract), p. 22.
28. Dilsen N, Konice M, Aral O, Ocal L. (1990) Our Diagnostic Criteria for FMF. The First International Symposium of Recurrent Hereditary Polyserositis, 28-29 April, Amman Jordan (Abstract), p. 50.
29. Dilsen N, Konice M, Aral O, Ocal L. (1990) Our Experience with Metaraminol Provocative Test in FMF. The First International Symposium on Recurrent Hereditary Polyserositis, Amman Jordan (Abstract), p. 3l 2.
30. Dagan T, Danon Y, Lotan R et al. Phenotype-genotype correlation in Familial Mediterranean Fever. In : Sohar E, Gafni J, Pras M, eds Familial mediterranean Fever. International Conference Book. London, Freund Publishing House Ltd 1997, p 239 45.